Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_provenance.
- NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_assertion description "[In the present study, we have targeted MMP-2 and MMP-9 overactivation in diabetic neuropathy using a known MMP-2 and MMP-9 inhibitor, minocycline, with a non-selective COX inhibitor, aspirin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_provenance.
- NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_assertion evidence source_evidence_curated NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_provenance.
- NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_assertion SIO_000772 20213226 NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_provenance.
- NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_assertion wasDerivedFrom ctd_human-20130708 NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_provenance.
- NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_assertion wasGeneratedBy ECO_0000218 NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_provenance.
- ctd_human-20130708 importedOn "2013-07-24" NP23034.RAMTa0k4wNYGgKAYGkgrVsjm0dWlirqANbAW2W-mBcP5c130_provenance.